Pediatric Intensive Care Unit, Apollo Children's Hospitals, Chennai, Tamil Nadu, India. Correspondence to: Dr. Suchitra Ranjit, Apollo Children's Hospital, Chennai, Tamil Nadu, India.
Pediatric Intensive Care Unit, Apollo Children's Hospitals, Chennai, Tamil Nadu, India.
Indian Pediatr. 2024 Mar 15;61(3):265-275. Epub 2024 Jan 9.
The three pathophysiologic contributors to septic shock include varying combinations of hypovolemia (relative > absolute), decreased vascular tone or vasoplegia, and myocardial dysfunction. The three pillars of hemodynamic support include fluid boluses, vasopressors with or without inotrope infusions. The three end-points of hemodynamic resuscitation include an adequate cardiac output (CO), adequate mean arterial pressure (MAP) and diastolic blood pressure (DBP) for organ perfusion, and avoiding congestion (worse filling) parameters. Only 33-50% of septic patients show post-fluid bolus CO improvements; this may be sustained in ≥10% on account of sepsis-mediated glycocalyx injury. A pragmatic approach is to administer a small bolus (10 mL/kg over 20-30 min) and judge the response based on clinical perfusion markers, pressure elements, and congestive features. Vasoplegia marked by low DBP is a major contributor to hypotension in septic shock. Hence, a strategy of restricted fluid bolus with early low-dose norepinephrine (NE) (0.05-0.1 µg/kg/min) can be helpful. NE may also be useful in septic myocardial dysfunction (SMD) as an initial agent to maintain adequate coronary perfusion and DBP while minimizing tachycardia and providing inotropy. Severe SMD may benefit from additional inotropy (epinephrine/dobutamine). Except vasopressin, most vasoactive drugs may safely be administered via a peripheral route. The lowest MAP (5th centile for age) may be an acceptable target, provided end-organ perfusion is satisfactory. A clinical individualized approach combining the history, serial physical examination, laboratory analyses, available monitoring tools, and repeated assessment to individualize circulatory support may to lead to better outcomes than one-size-fits-all algorithms.
导致感染性休克的三个病理生理因素包括不同程度的低血容量(相对或绝对)、血管张力降低或血管麻痹以及心肌功能障碍。血流动力学支持的三个支柱包括液体冲击、血管加压素加或不加正性肌力药物输注。血流动力学复苏的三个终点包括足够的心输出量(CO)、足够的平均动脉压(MAP)和舒张压(DBP)以保证器官灌注,以及避免充血(充盈过度)参数。只有 33-50%的感染性休克患者在液体冲击后 CO 得到改善;由于感染介导的糖萼损伤,≥10%的患者可能会持续改善。一种实用的方法是给予小剂量冲击(10 mL/kg 于 20-30 分钟内输注),并根据临床灌注标志物、压力元素和充血特征来判断反应。以低 DBP 为特征的血管麻痹是感染性休克低血压的主要原因。因此,早期给予小剂量去甲肾上腺素(NE)(0.05-0.1 µg/kg/min)限制液体冲击的策略可能会有所帮助。NE 也可用于感染性心肌功能障碍(SMD),作为维持足够冠状动脉灌注和 DBP、最小化心动过速和提供正性肌力的初始药物。严重的 SMD 可能受益于额外的正性肌力(肾上腺素/多巴酚丁胺)。除了血管加压素,大多数血管活性药物都可以通过外周途径安全给药。只要终末器官灌注满意,最低 MAP(年龄的第 5 百分位数)可能是可接受的目标。结合病史、连续体格检查、实验室分析、可用监测工具和个体化循环支持的重复评估的个体化临床方法可能比一刀切的算法导致更好的结果。